GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Overview Fund Activity
Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

113 hedge funds and large institutions have $541M invested in G1 Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 43 increasing their positions, 31 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
113
Holders Change
-9
Holders Change %
-7.38%
% of All Funds
1.97%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
11
Increased
43
Reduced
31
Closed
20
Calls
$7.08M
Puts
$6.33M
Net Calls
+$749K
Net Calls Change
+$2.97M

Top Buyers

1
Fisher Asset Management
1
Fisher Asset Management
Washington
$20.1M
2
Morgan Stanley
2
Morgan Stanley
New York
$12.6M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$8.77M
4
TCM
4
Tekla Capital Management
Massachusetts
$13.7M
5
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$23.5M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$18.2M
2
CLOS
2
Compagnie Lombard Odier SCmA
Switzerland
$0
3
Two Sigma Investments
3
Two Sigma Investments
New York
$13.7M
4
Goldman Sachs
4
Goldman Sachs
New York
$9.73M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$70.9M +$1.77M +80,859 +3%
State Street
2
State Street
Massachusetts
$60.8M +$880K +40,111 +1%
Vanguard Group
3
Vanguard Group
Pennsylvania
$54.9M +$1.36M +61,841 +3%
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$41.2M +$1.06M +48,271 +3%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$23.5M +$4.94M +225,057 +27%
Fisher Asset Management
6
Fisher Asset Management
Washington
$20.1M +$20.1M +914,838 New
Nuveen Asset Management
7
Nuveen Asset Management
Illinois
$19.5M +$4.39M +200,034 +29%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$18.2M -$16.9M -771,259 -48%
LOAMS
9
Lombard Odier Asset Management (Switzerland)
Switzerland
$17.9M +$4.69M +213,725 +36%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$17.9M +$900 +41 +0%
MB
11
MPM BioImpact
Massachusetts
$17.8M -$2.52M -115,000 -12%
Two Sigma Investments
12
Two Sigma Investments
New York
$13.7M -$4.64M -211,522 -25%
TCM
13
Tekla Capital Management
Massachusetts
$13.7M +$5.1M +232,615 +59%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$13.4M +$1.3M +59,141 +11%
Morgan Stanley
15
Morgan Stanley
New York
$12.6M +$7.36M +335,635 +142%
Two Sigma Advisers
16
Two Sigma Advisers
New York
$11.9M -$1.58M -72,000 -12%
Goldman Sachs
17
Goldman Sachs
New York
$9.73M -$2.82M -128,536 -22%
Northern Trust
18
Northern Trust
Illinois
$9.22M +$980K +44,685 +12%
Point72 Asset Management
19
Point72 Asset Management
Connecticut
$8.77M +$5.48M +249,908 +167%
Voloridge Investment Management
20
Voloridge Investment Management
Florida
$7.62M +$82.5K +3,758 +1%
Bank of America
21
Bank of America
North Carolina
$7.5M +$1.55M +70,500 +26%
RPAM
22
Rhenman & Partners Asset Management
Sweden
$7.13M – – –
Charles Schwab
23
Charles Schwab
California
$5.26M +$286K +13,054 +6%
Nordea Investment Management
24
Nordea Investment Management
Sweden
$4.15M +$4.15M +189,315 New
Citigroup
25
Citigroup
New York
$4.08M +$205K +9,336 +5%
1
2 3 4 5